Liganded Gz-activating GPCRs bind inactive heterotrimeric G-protein Gz

Stable Identifier
R-HSA-749446
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Gz is predominantly expressed in the nervous system and platelets. Gz interacts with receptors for many neurotransmitters and neuropeptides, including the adenosine A1, alpha2-adrenergic, dopamine D2, 5-HT1A, muscarinic M2, substance P, and all types of opioid receptors. In addition, Gz is capable of transducing signals from receptors such as the C5a and formyl peptide receptors. All these receptors can also signal via Gi. (Ho & Wong 2001).
Literature References
PubMed ID Title Journal Year
10954748 Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs

Blendy, JA, Lucki, I, Manning, D, Dalvi, A, Yang, J, Poncz, M, Kowalska, MA, Brass, LF, O'Brien, PJ, Wu, J, Prevost, N

Proc Natl Acad Sci U S A 2000
11313909 G(z) signaling: emerging divergence from G(i) signaling

Ho, MK, Wong, YH

Oncogene 2001
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!